Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies

A composition comprising a molecule or molecule complex, wherein the molecule or molecule complex comprises a TLR9 binding part capable of binding to TLR9, a CD32 binding part capable of binding to CD32, and at least one antigen,

• wherein the CD32 binding part is selected from the group consisting of CD32-binding protein domains, CD32-binding peptides, and CD32-binding nucleic acids, and
• wherein the TLR9 binding part is a CpG oligodeoxynucleotide.